Mankind Pharma profit jumps 30% on chronic therapy demand in Q4
New Delhi: Mankind Pharma on Tuesday reported a 30% year-on-year rise in fourth-quarter revenue, pushed by robust demand for persistent ...
- Latest
New Delhi: Mankind Pharma on Tuesday reported a 30% year-on-year rise in fourth-quarter revenue, pushed by robust demand for persistent ...
Copyright © 2022 Asia Today.